Blog
About

9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Dose response and therapeutic index of inhaled corticosteroids in asthma.

      Current Opinion in Pulmonary Medicine

      Treatment Outcome, Severity of Illness Index, Risk Assessment, Respiratory Function Tests, Randomized Controlled Trials as Topic, Prognosis, Male, Humans, Female, Drug Administration Schedule, Dose-Response Relationship, Drug, drug therapy, diagnosis, Asthma, adverse effects, administration & dosage, Adrenal Cortex Hormones, Administration, Inhalation

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inhaled glucocorticoids play an indispensable role in the therapy of asthma. Development of new compounds was initially directed to increase the potency of the individual corticosteroid; thereafter, pharmacokinetic characteristics were modified to reduce unwanted systemic effects. Target of the present development is to attain compounds with the most favorable risk-to-benefit ratios. Since then, there has been substantial discussion about how to rank and weigh the different glucocorticoids. This article provides an evaluation of the relevant clinical studies published between May 2001 and June 2002, identifying the main determinants of the therapeutic value of inhaled glucocorticoids.

          Related collections

          Author and article information

          Journal
          12476077

          Comments

          Comment on this article